New Website Coming! As part of our merger with St. Paul Research, we’re creating a new website that will house all of our collective content under one roof, bringing you a higher level of research and service through their analysts’ additional insight, expertise, and perspective. Be on the lookout for more information in advance of our new website launch on Tuesday, May 18.

Ray Blanco’s FDA Profit Alert

Ray Blanco's FDA Profit Alert focuses on medical tech stocks with prices that move based on triggers generally unknown to the market.

It is designed to alert you to breakout moves could ultimately drive huge stock market gains...

Two Biotechs That Will Shine Bright in 2018

Despite the quiet, there is market-making news for us this week, as the Food and Drug Administration announced a delay in processing an application for one of our triple-digit winners... Plus, we're taking a look forward to a calendar packed with profit-generating catalysts in the new year.

You Must Be A Subscriber To View This Content.

If you are already a subscriber, click the login button below to get access. Not yet a subscriber? Checkout our publication below and get access today!


Ray Blanco’s FDA Profit Alert

The FDA Profit Alert focuses on medical tech stocks with prices that move based on triggers generally unknown to the market. It is designed to alert you to breakout moves in the medical markets that could ultimately drive huge stock market gains. It’s the single best way to connect the dots that link today’s dynamic, innovative medical market.

LoginGet Access

Ray Blanco

Ray Blanco is the editor of Technology Profits Confidential as well as Breakthrough Technology Alert, FDA Profit Alert, and Technology Profits Daily. Ray has been with Seven Figure Publishing since 2010. In 2019, his closed positions in Technology Profits Confidential outperformed the S&P500 by 50%.

View More By Ray Blanco